Protagonist Therapeutics Inc (PTGX)

41.49 +1.95 (+4.93%) USD  |  NASDAQ  |  Dec 20, 16:00
41.51 +0.02 (+0.05%) After-Hours: 20:00
More

Protagonist Therapeutics Max Drawdown (5Y): 85.79% for Nov. 30, 2024

Max Drawdown (5Y) Chart

View Max Drawdown (5Y) for PTGX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Max Drawdown (5Y) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Max Drawdown Definition

View Max Drawdown Definition
Start Trial

Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.

Read full definition.

Max Drawdown (5Y) Range, Past 5 Years

View Max Drawdown (5Y) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Max Drawdown (5Y) Benchmarks

View Max Drawdown (5Y) Benchmarks
Start Trial
Assembly Biosciences Inc 98.41%
Precision BioSciences Inc 98.90%
Entrada Therapeutics Inc --
NovaBay Pharmaceuticals Inc 99.98%
Palatin Technologies Inc 97.38%

Max Drawdown (5Y) Related Metrics

Alpha (5Y) 6.658
Beta (5Y) 2.178
Annualized Standard Deviation of Monthly Returns (5Y Lookback) 96.53%
Historical Sharpe Ratio (5Y) 0.3704
Historical Sortino (5Y) 0.6469
Monthly Value at Risk (VaR) 5% (5Y Lookback) 27.81%